Inclusion Criteria : 
  -  Have Type II diabetes
  -  Body mass index ( BMI ) of  25 -  40 kilograms per square meter ( kg / m² )  , inclusive
  -  Have a body weight of <  150 kilograms ( kg ) 
  -  Have clinical lab test results within normal reference range for the population or investigator site , or results with acceptable deviations that are judged to be not clinically significant by the investigator; however , should have serum magnesium and potassium levels , along with lactate dehydrogenase , CK values within the normal range at screening and Day -  2. 
Exclusion Criteria : 
  -  Have Type  1 diabetes or latent autoimmune diabetes in adults
  -  Have uncontrolled diabetes defined as an episode of ketoacidosis or hyperosmolar state requiring hospitalization for  6 months prior to screening
  -  Have had an episode of severe hypoglycemia , defined by the occurrence of neuroglycopenic symptoms requiring the assistance of another person for recovery , within  6 months prior to Visit  1 
  -  Have an abnormal  12 - lead electrocardiogram ( ECG ) at screening and / or Day -  2 that , in the opinion of the investigator , increases the risks associated with participating in the study or may confound ECG data analysis
  -  Have poorly controlled hypertension at screening; or a change in antihypertensive medication within  30 days of screening
  -  Have an estimated glomerular filtration rate <  45 milliliters per minute per  1.73 meters squared of body surface area ( mL / min /  1.73 m² ) 